Gilead Sciences Inc - Company & Market Research Reports

Home /
Companies /
Gilead Sciences Inc

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 162
Infectious Diseases Drugs 123
Genomics 101
Liver and Kidney Disorders Drugs 68
Immune Disorders Drugs 61
Pharmaceuticals 51
Drug Discovery 48
Cardiovascular Drugs 44
Biopharmaceuticals 42
Biotechnology 41
Leukemia Drugs 36
HIV/AIDS Drugs 36
Lymphoma Drugs 29
Allergy and Immunology 28
Clinical Trials 28
Musculoskeletal Disorders Drugs 27
Enzymes 26
Respiratory Drugs 26
Oncology 22
Pulmonary Medicine 21
Central Nervous System Drugs 20
Infusions and Injectables 19
Drug Delivery 19
Pharmaceutical Manufacturing 17
Gastrointestinal Drugs 13
Infectious Disease Testing 12
Vaccines 12
Endocrine and Metabolic Disorders Drugs 11
Healthcare Services 10
Diagnostics 10
Hematology 10
Hematological Drugs 10
Sexual and Reproductive Health Drugs 10
Antibiotics 9
Pharmaceutical Intermediates 8
Therapeutic Area 8
Optical Disorders Drugs 8
Breast Cancer Drugs 8
Stem Cells 8
Drugs by Therapeutic Area 6
Women's Health 6
Lung Cancer Drugs 6
Company Reports 5
Hepatology 5
Colon Cancer Drugs 5
Analgesics 5
Needles and Syringes 5
Nanomedicine 5
Cervical Cancer Drugs 4
Anesthetic Drugs 4
Biomarkers 4
Dermatology 4
Skin Cancer Drugs 4
Dermatological Drugs 4
Immunosuppressive Drugs 4
Addiction Disorders Drugs 3
Liver Cancer Drugs 3
Generic Drugs 3
Bladder Cancer Drugs 3
Dental 3
Optical 3
Medical Devices 3
Over the Counter (OTC) Drugs 3
Mental Disorders Drugs 3
Biosimilars and Biosuperiors 3
E-Healthcare 2
Pharmacoeconomics 2
Prostate Cancer Drugs 2
Ovarian Cancer Drugs 2
Brain Cancer Drugs 2
In Vitro Diagnostics 2
Cancer Vaccines 2
Kidney Cancer Drugs 2
Vitamins and Dietary Supplements 2
Laboratory Equipment 2
Pediatrics 2
Gastroenterology 2
Cardiology 2
Urological Disorders Drugs 2
Animal Pharmaceuticals 1
Neurology 1
Urology and Nephrology 1
Fertility Services 1
Proteomics 1
Cardiovascular Devices 1
Home Testing and Home Healthcare 1
Healthcare 1
Managed Care 1
Transdermal and Transmucosal Drug Delivery 1
Inhalers and Nebulisers 1
Blood Banking 1
Hospital Management 1
Surgical Procedures 1
Pancreatic Cancer Drugs 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Anatomy 1
Endocrinology 1
Alzheimer's Disease Drugs 1
Asthma Drugs 1
Bronchitis Drugs 1
Schizophrenia Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



282 reviews

1,019 Results (Page 29 of 51)
- Relevance
  Sort by

Cardiovascular Drugs - Global Strategic Business Report

 Report
April 2026
413 Pages
Global

From

€5237EUR$5,850USD£4,574GBP

Angina Pectoris Drugs - Global Strategic Business Report

 Report
April 2026
196 Pages
Global

From

€5237EUR$5,850USD£4,574GBP

Atrial Fibrillation Drugs Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
May 2023
91 Pages
Global

From

€3500EUR$4,189USD£3,164GBP

Non-alcoholic Steatohepatitis Clinical Trials - Global Strategic Business Report

 Report
April 2026
144 Pages
Global

From

€5237EUR$5,850USD£4,574GBP

Cystic Fibrosis Lung Disease Market: Analysis By Drug Type, Route of Administration, Distribution Channel, By Region, By Country: Market Insights and Forecast

 Report
January 2024
250 Pages
Global

From

€2193EUR$2,450USD£1,916GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Viral Hepatitis Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4019EUR$4,490USD£3,511GBP

Hepatitis B Virus (HBV) Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4019EUR$4,490USD£3,511GBP

Breast Cancer Therapeutics Market Size and Forecasts 2020-2030, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy, Breast Cancer Type, Distribution Channel, and Geography

 Report
October 2023
204 Pages
Global

From

€3983EUR$4,450USD£3,479GBP

Condyloma - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1790EUR$2,000USD£1,564GBP

Congestive Heart Failure Market - Global Forecast 2026-2032

 Report
January 2026
186 Pages
Global

From

€3173EUR$3,545USD£2,772GBP

€3526EUR$3,939USD£3,080GBP

Penicillin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
May 2025
180 Pages
Global

From

€4028EUR$4,500USD£3,519GBP

Europe Cell & Gene Therapy Market - Focused Insights 2024-2029

 Report
June 2024
103 Pages
Europe

From

€1969EUR$2,200USD£1,720GBP

Atopic Dermatitis Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4019EUR$4,490USD£3,511GBP

Cutaneous and Systemic Leishmaniasis Market - Global Strategic Business Report

 Report
April 2026
473 Pages
Global

From

€5237EUR$5,850USD£4,574GBP

Bird Flu Treatment Market - Global Strategic Business Report

 Report
April 2026
285 Pages
Global

From

€5237EUR$5,850USD£4,574GBP

Candidiasis Therapeutics Market - Global Strategic Business Report

 Report
April 2026
474 Pages
Global

From

€5237EUR$5,850USD£4,574GBP

Oral Antivirals Market - Global Strategic Business Report

 Report
April 2026
380 Pages
Global

From

€5237EUR$5,850USD£4,574GBP

Antivirals Drug - Global Strategic Business Report

 Report
April 2026
362 Pages
Global

From

€5237EUR$5,850USD£4,574GBP

Anti-Infectives - Global Strategic Business Report

 Report
April 2026
158 Pages
Global

From

€5237EUR$5,850USD£4,574GBP

Antifungal Drugs - Global Strategic Business Report

 Report
April 2026
179 Pages
Global

From

€5237EUR$5,850USD£4,574GBP

1,019 Results (Page 29 of 51)
- 1
- 27
- 28
- 29
- 30
- 31

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.